Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Characterization and microbiological evaluation of chitosan-alginate microspheres for cefixime vaginal administration (CROSBI ID 249894)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Maestrelli, Francesca ; Jug, Mario ; Cirri, Marzia ; Kosalec, Ivan ; Mura, Paola Characterization and microbiological evaluation of chitosan-alginate microspheres for cefixime vaginal administration // Carbohydrate polymers, 192 (2018), 176-183. doi: 10.1016/j.carbpol.2018.03.054

Podaci o odgovornosti

Maestrelli, Francesca ; Jug, Mario ; Cirri, Marzia ; Kosalec, Ivan ; Mura, Paola

engleski

Characterization and microbiological evaluation of chitosan-alginate microspheres for cefixime vaginal administration

Chitosan-alginate microspheres (MS) were developed for cefixime vaginal administration, to overcome problems associated with its oral administration. The effect of increasing drug-loading amount, by keeping the chitosan-alginate content constant, was investigated. Mucoadhesion studies indicated that all formulations assured in situ permanence longer than 2 h. Entrapment efficiency increased with drug loading concentration in the starting solution, reaching a plateau at 30 mg/mL indicative of the achievement of an optimal drug-to-polymer ratio. MS swelling properties increased with the entrapped drug amount, and, interestingly, water-uptake reached its maximum value at the same drug loading concentration of 30 mg/mL. The relationship found between MS water-uptake and drug release rate confirmed MS prepared with 30 mg/mL cefixime as the best formulation. Microbiological studies showed a relation between cefixime release rate from MS and Escherichia coli viability reduction, definitely indicating the selected MS formulation as the best for an effective local treatment of urogenital infections.

chitosan ; alginate ; microspheres ; vaginal delivery ; mucoadhesion ; cefixime

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

192

2018.

176-183

objavljeno

0144-8617

1879-1344

10.1016/j.carbpol.2018.03.054

Povezanost rada

Farmacija

Poveznice
Indeksiranost